Search

Your search keyword '"Ziad A. Massy"' showing total 685 results

Search Constraints

Start Over You searched for: Author "Ziad A. Massy" Remove constraint Author: "Ziad A. Massy"
685 results on '"Ziad A. Massy"'

Search Results

1. Antihypertensive Treatment Patterns in CKD Stages 3 and 4: The CKD-REIN Cohort Study

2. De-indexed estimated glomerular filtration rates for the dosing of oral antidiabetic drugs in patients with chronic kidney disease

3. Identification of endophenotypes supporting outcome prediction in hemodialysis patients based on mechanistic markers of statin treatment

4. Urea Level and Depression in Patients with Chronic Kidney Disease

5. International practice patterns of dyslipidemia management in patients with chronic kidney disease under nephrology care: is it time to review guideline recommendations?

6. Longitudinal uric acid has nonlinear association with kidney failure and mortality in chronic kidney disease

7. Methodological challenges and biases in the field of cognitive function among patients with chronic kidney disease

8. Consequences of oral antithrombotic use in patients with chronic kidney disease

9. Metformin prevents stroke damage in non-diabetic female mice with chronic kidney disease

10. Proton-Pump Inhibitors and Serum Concentrations of Uremic Toxins in Patients with Chronic Kidney Disease

11. Adherence to the Kidney Disease: Improving Global Outcomes CKD Guideline in Nephrology Practice Across Countries

12. Probiotic Intake and Inflammation in Patients With Chronic Kidney Disease: An Analysis of the CKD-REIN Cohort

13. Practice patterns of dialysis access and outcomes in patients wait-listed early for kidney transplantation

14. Correlation between Saliva Levels and Serum Levels of Free Uremic Toxins in Healthy Volunteers

15. Achievement of Low-Density Lipoprotein Cholesterol Targets in CKD

16. Strategies for Phosphate Control in Patients With CKD

17. Serum concentration and vascular expression of adiponectin are differentially associated with the diabetic calcifying peripheral arteriopathy

18. Assessment of Thrombotic and Bleeding Tendency in Two Mouse Models of Chronic Kidney Disease: Adenine-Diet and 5/6th Nephrectomy

19. The epidemiology of renal replacement therapy in two different parts of the world: the Latin American Dialysis and Transplant Registry versus the European Renal Association-European Dialysis and Transplant Association Registry

20. Prediction of chronic kidney disease after acute kidney injury in ICU patients: study protocol for the PREDICT multicenter prospective observational study

21. Syndecan-1 and Free Indoxyl Sulfate Levels Are Associated with miR-126 in Chronic Kidney Disease

22. Association of plasma potassium with mortality and end-stage kidney disease in patients with chronic kidney disease under nephrologist care - The NephroTest study

23. Hypertension Control, Apparent Treatment Resistance, and Outcomes in the Elderly Population With Chronic Kidney Disease

24. Intestinal Chelators, Sorbants, and Gut-Derived Uremic Toxins

25. Correction to: Association of plasma potassium with mortality and end-stage kidney disease in patients with chronic kidney disease under nephrologist care - The NephroTest study

26. Association between Uremic Toxin Concentrations and Bone Mineral Density after Kidney Transplantation

27. Uremic Toxins and Vascular Dysfunction

28. Difference in Profiles of the Gut-Derived Tryptophan Metabolite Indole Acetic Acid between Transplanted and Non-Transplanted Patients with Chronic Kidney Disease

29. Differential Effects of Indoxyl Sulfate and Inorganic Phosphate in a Murine Cerebral Endothelial Cell Line (bEnd.3)

30. The quest for a better understanding of chronic kidney disease complications: an update on uremic toxins

31. Neurological Disorders in a Murine Model of Chronic Renal Failure

32. New Insights into the Roles of Monocytes/Macrophages in Cardiovascular Calcification Associated with Chronic Kidney Disease

33. Endothelial Microparticles in Uremia: Biomarkers and Potential Therapeutic Targets

34. Association between Free Light Chain Levels, and Disease Progression and Mortality in Chronic Kidney Disease

35. Calcificação vascular em doença renal crônica: uma revisão

36. Protein-Bound Uremic Toxins: New Insight from Clinical Studies

37. Uremia Impacts VE-Cadherin and ZO-1 Expression in Human Endothelial Cell-to-Cell Junctions

38. The Impact of Uremic Toxins on Cerebrovascular and Cognitive Disorders

39. Uremic Toxins and Clinical Outcomes: The Impact of Kidney Transplantation

40. The Impact of Uremic Toxins on Vascular Smooth Muscle Cell Function

41. N-methyl-2-pyridone-5-carboxamide (2PY)—Major Metabolite of Nicotinamide: An Update on an Old Uremic Toxin

42. Machine Learning-Based Urine Peptidome Analysis to Predict and Understand Mechanisms of Progression to Kidney Failure

44. Preparing European Nephrology for the next pandemic

45. Work status and work ability of patients receiving kidney replacement therapy

46. Vascular calcification in chronic kidney disease: contribution of ferroptosis?

47. The Role of Uremic Retention Solutes in the MIA Syndrome in Hemodialysis Subjects

48. Association of Serum Phosphate with Efficacy of Statin Therapy in Hemodialysis Patients

49. Effect of Sevelamer and Nicotinamide on Albumin Carbamylation in Patients with End-Stage Kidney Disease

Catalog

Books, media, physical & digital resources